Neurosciencenpj Drug Discovery.Peer-reviewed
Development of Potent, Selective cPLA2 Inhibitors for Targeting Neuroinflammation in Alzheimer's Disease and Other Neurodegenerative Disorders
Anastasiia Sadybekov, Marlon Vincent V. Duro, Shaowei Wang…·Hussein N. Yassine
This study identifies a potent cPLA2 inhibitor, BRI-50460, that modulates neuroinflammation and lipid homeostasis in Alzheimer's disease models.
8 citationstop 1%